PAVmed (PAVM) Invested Capital (2015 - 2025)

PAVmed's Invested Capital history runs 11 years deep, the most recent figure standing at $33.4 million for Q4 2025.

• In Q4 2025, Invested Capital rose 25.54% year-over-year to $33.4 million; the TTM figure through Dec 2025 stood at $33.4 million (up 25.54% YoY), while the FY2025 annual figure was $33.4 million, up 25.54% from the prior year.
• Invested Capital was $33.4 million for Q4 2025 at PAVmed, down from $39.4 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $79.4 million in Q4 2021 to a low of -$570000.0 in Q2 2023.
• Historically, Invested Capital has averaged $40.1 million across 5 years, with a median of $37.3 million in 2021.
• The sharpest annual moves came in 2021 and 2023: Invested Capital jumped 8424.75% in 2021, then sank 100.8% in 2023.
• A 5-year view of Invested Capital shows it stood at $79.4 million in 2021, then plunged by 43.86% to $44.6 million in 2022, then sank by 54.73% to $20.2 million in 2023, then surged by 31.83% to $26.6 million in 2024, then rose by 25.54% to $33.4 million in 2025.
• The last three Invested Capital figures came in at $33.4 million (Q4 2025), $39.4 million (Q3 2025), and $35.0 million (Q2 2025), per Business Quant data.